As we described in a previous article, the Global Cannabis Stock Index fell sharply in March, plunging 15.2%, leaving it down 12.5% in the first quarter of the year. This followed a record decline of 70.4% for 2022. In April, the index dropped again, falling 2.9% to 8.25
In this exclusive article we will summarize the performance of the other managed indices that New Cannabis Ventures offers to its readers. We will discuss the performance of the American Cannabis Operator Index, Ancillary Cannabis Index and Canadian Cannabis LP Index as well as Canadian Cannabis LP index Tier 1, 2 and 3.
American Cannabis Stocks Index
The American Cannabis Operator Index fell slightly. In March, the index plunged 14.0%, and it fell just 0.2% in April to 13.00:
Down 8.6% in Q1, the index is down now 8.8% in 2023, ahead of the Global Cannabis Stock Index. Over the past year, the index has declined 56.8%:
The index, which launched in October 2018, finally took out the low from March 2020 in late 2022 and extended the decline in April:
During April, two stocks provided investors double-digit percentage gains, Ayr Wellness (OTC: AYRWF) (CSE: AYR.A), up 11.7%, and TerrAscend (OTC: TRSSF) (CSE: TER), up 10.5%. Curaleaf Holdings (OTC: CURLF) (CSE: CURA) was the worst performer in the index, declining 8.9%.
In May, the index will drop to 10 members with the deletion of Ayr Wellness due to its daily trading value falling below the minimum.
Ancillary Cannabis Index
The Ancillary Cannabis Index dropped 2.0% to 13.51:
The index, with a massive loss of 76.6% in 2022 to 15.02, has declined 67.6% over the past year. It is down 10.1% in 2023:
The index is down over 86% since launching at the end of March in 2021:
The best performing stock in the index in April was Turning Point Brands (NYSE: TPB), which rose 13.3%. The worst stock was WM Technology (NASDAQ: MAPS), which dropped 14.6%.
In May, the index will decrease to 6 members with the removals of Hydrofarm (NASDAQ: HYFM), WM Technology and NewLake Capital (NASDAQ: NLCP).
Canadian Cannabis LP Index
The Canadian Cannabis LP Index was very strong to begin the year, rising 19.4% in January and falling just slightly in February, but the index plunged 15.4% in March. In April, it rose 2.9% to 74.77:
The index, up 0.1% in Q1 after falling 11.4% in Q4 , declined 62.8% in 2022 to 72.59. It is up 3.0% so far in 2023. Over the last year, it has dropped by 46.1%.
The index, which made a new all-time low in December, is down a lot from its peak:
During the month, we ended the reporting of three sub-indices in Canada that were based on the size of the company by revenue. During April, the index was helped by the 160% gain in Canadabis Capital (TSXV: CANB). Canopy Growth (TSX: WEED) (NASDAQ: CGC) was the worst-performing stock, dropping 26.2%. Organigram (TSX: OGI) (NASDAQ: OGI) was down substantially as well, dropping 20.9%.
New Cannabis Ventures maintains four proprietary indices designed to help investors monitor the publicly-traded cannabis stocks, including the Global Cannabis Stock Index as well as the Canadian Cannabis LP Index. The third index, the American Cannabis Operator Index, was launched at the end of October 2018 and tracks the leading cultivators, processors and retailers of cannabis in the United States. Afterwards, we introduced the Ancillary Cannabis Index at the end of March 2021, reflecting the increasing number of publicly-traded companies providing goods or services to cannabis operators.